VEXTF

Vext Science Inc. (VEXTF) reported strong Q3 2025 results, with revenue up 41% year-over-year to $12.7 million. This growth was fueled by expanded retail operations in Ohio and resilient performance in Arizona. Year-to-date operating cash flow reached $8.5 million, a significant improvement from the previous year. Vext is on track to reach the Ohio dispensary license cap of eight by 2026, positioning itself for continued growth in the adult-use market. The company maintains a focus on maximizing dispensary performance and strategic expansion.